{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T08:15:54Z","timestamp":1786263354201,"version":"build-2736575974"},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.2169\/internalmedicine.5410-20","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T22:07:07Z","timestamp":1595887627000},"page":"3051-3054","source":"Crossref","is-referenced-by-count":5,"title":["Nephrotic Syndrome with Focal Segmental Glomerulosclerosis Induced by Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitor"],"prefix":"10.2169","volume":"59","author":[{"given":"Kota","family":"Kakeshita","sequence":"first","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Koike","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiko","family":"Imamura","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Murai","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Fujioka","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358: 1129-1136, 2008.","DOI":"10.1056\/NEJMoa0707330"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hanna RM, Lopez E, Hasnain H, et al. Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension. Clin Kidney J 12: 92-100, 2019.","DOI":"10.1093\/ckj\/sfy060"},{"key":"3","doi-asserted-by":"crossref","first-page":"e022031","DOI":"10.1136\/bmjopen-2018-022031","volume":"9","author":"B Pham","year":"2019","unstructured":"3. Pham B, Thomas SM, Lillie E, et al. Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis. BMJ Open 9: e022031, 2019.","journal-title":"BMJ Open","ISSN":"https:\/\/id.crossref.org\/issn\/2044-6055","issn-type":"print"},{"key":"4","unstructured":"4. Stewart MW. Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug. Br J Ophthalmol 96: 1157-1158, 2012."},{"key":"5","unstructured":"5. Zhu X, Wu S, Dahut WL, Parikh CR. Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis. Am J Kidney Dis 49: 186-193, 2007."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Estrada CC, Maldonado A, Mallipattu SK. Therapeutic inhibition of VEGF signaling and associated nephrotoxicities. J Am Soc Nephrol 30: 187-200, 2019.","DOI":"10.1681\/ASN.2018080853"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Georgalas I, Papaconstantinou D, Papadopoulos K, Pagoulatos D, Karagiannis D, Koutsandrea C. Renal injury following intravitreal anti-VEGF administration in diabetic patients with proliferative diabetic retinopathy and chronic kidney disease - a possible side effect? Curr Drug Saf 9: 156-158, 2014.","DOI":"10.2174\/1574886309666140211113635"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Pelle G, Shweke N, Duong Van Huyen JP, et al. Systemic and kidney toxicity of intraocular administration of vascular endothelial growth factor inhibitors. Am J Kidney Dis 57: 756-759, 2011.","DOI":"10.1053\/j.ajkd.2010.11.030"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sato T, Kawasaki Y, Waragai T, et al. Relapse of minimal change nephrotic syndrome after intravitreal bevacizumab. Pediatr Int 55: e46-e48, 2013.","DOI":"10.1111\/ped.12017"},{"key":"10","unstructured":"10. Hanna RM, Barsoum M, Arman F, Selamet U, Hasnain H, Kurtz I. Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence. Kidney Int 96: 572-580, 2019."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Avery RL, Castellarin AA, Steinle NC, et al. Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD. Br J Ophthalmol 98: 1636-1641, 2014.","DOI":"10.1136\/bjophthalmol-2014-305252"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/23\/59_5410-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T04:54:25Z","timestamp":1607144065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/23\/59_5410-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":11,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5410-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}